Health Care & Life Sciences » Biotechnology | Calithera Biosciences Inc.

Calithera Biosciences Inc. | Ownership

Companies that own Calithera Biosciences Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Wellington Management Co. LLP
4,892,594
13.6%
-93,870
0.01%
06/30/2018
BlackRock Fund Advisors
2,745,476
7.63%
122,244
0%
06/30/2018
BVF Partners LP
2,019,000
5.61%
2,019,000
0.74%
09/04/2018
Federated Global Investment Management Corp.
1,888,900
5.25%
466,700
0.07%
06/30/2018
The Vanguard Group, Inc.
1,197,840
3.33%
76,458
0%
06/30/2018
Numeric Investors LLC
835,792
2.31%
-98,890
0.03%
06/30/2018
Dimensional Fund Advisors LP
792,300
2.2%
319,906
0%
06/30/2018
Adage Capital Management LP
700,000
1.95%
0
0.01%
06/30/2018
American Century Investment Management, Inc.
552,904
1.54%
-243,822
0%
06/30/2018
SSgA Funds Management, Inc.
531,347
1.48%
3,204
0%
06/30/2018

About Calithera Biosciences

View Profile
Address
343 Oyster Point Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.calithera.com
Updated 07/08/2019
Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.